Table 1 Baseline characteristics of the subjects enrolled in the trial
N. 40 | Mean | SD | Mean | SD | |
|---|---|---|---|---|---|
Age (years) | 53.45 | 8.00 | Total Cholesterol (mg/dL) | 215.70 | 15.20 |
Weight (kg) | 82.00 | 11.45 | LDL-C (mg/dL) | 132.15 | 17.50 |
Body Mass Index (kg/m2) | 28.75 | 2.65 | Triglycerides (mg/dL) | 222.05 | 38.70 |
Waist Circumference (cm) | 106.30 | 10.85 | HDL-C (mg/dL) | 39.10 | 3.40 |
SBP (mmHg) | 135.50 | 14.90 | Non HDL-C (mg/dL) | 176.60 | 15.40 |
DBP (mmHg) | 80.60 | 7.30 | GOT (U/L) | 24.90 | 10.10 |
Pulse Pressure (mmHg) | 54.90 | 12.10 | GPT (U/L) | 28.10 | 12.95 |
MAP (mmHg) | 98.95 | 8.75 | Serum Uric Acid (mg/dL) | 4.50 | 1.30 |
Heart Rate (bpm) | 73.80 | 5.60 | Creatinine (mg/dL) | 8.95 | 1.25 |
FPG (mg/dL) | 106.90 | 6.70 | LAP | 111.40 | 34.35 |
Insulin (μU/ml) | 14.50 | 4.30 | HSI | 37.05 | 3.60 |
HOMA-IR | 4.05 | 1.20 |